Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral

被引:2
|
作者
Chu, SH
Pang, ST
Chiang, YJ
Chuang, CK
Chen, HW
Chen, CS
Chou, CC
Huang, CC
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan
关键词
D O I
10.1016/S0041-1345(98)01121-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:3521 / 3523
页数:3
相关论文
共 50 条
  • [31] Cyclosporine bioavailability of neoral and sandimmune in white and black de novo renal transplant recipients
    Pollak, R
    Wong, RL
    Chang, CT
    THERAPEUTIC DRUG MONITORING, 1999, 21 (06) : 661 - 663
  • [32] Changing stable heart transplant recipients from sandimmune to neoral
    DalrympleHay, M
    Meara, M
    Reynolds, L
    Backhouse, L
    Wright, D
    Holt, D
    Johnston, A
    Madden, B
    Murday, A
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2285 - 2286
  • [33] Conversion from once-daily sandimmune cyclosporine to once-daily neoral in renal transplant patients
    Arvind, C
    Vathsala, A
    Woo, KT
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1681 - 1682
  • [34] Effect of conversion from sandimmune to neoral on glomerular filtration rate in stable renal transplant recipients
    Steinmuller, D
    Dougherty, J
    Coutee, J
    Surek, D
    Swies, G
    Lewis, R
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 298 - 299
  • [35] Estimation of mean relative bioavailability of cyclosporine Sandimmune and Neoral using NONMEM in renal transplant recipients
    Lee, KL
    Lee, KT
    Chung, HM
    Lin, YP
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3526 - 3529
  • [36] Comparison of renal transplant outcome with Neoral versus Sandimmune as part of an initial triple therapy regimen
    AlShaibani, K
    Raza, S
    AlFurayh, O
    AlMeshari, K
    AlAhmadi, I
    AlSabban, E
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3519 - 3520
  • [37] Sequential substitution from Sandimmune to Implanta and from Implanta to its microemulsion formulation, Neoplanta, as cyclosporine preparations in renal transplant patients.
    Kim, HJ
    Song, SC
    KIDNEY INTERNATIONAL, 1998, 54 (05) : 1808 - 1809
  • [38] Conversion from sandimmune to neoral at two different dose-ratio in stable renal transplant patients.
    Gaspari, F
    Perico, N
    Pisoni, R
    Anedda, MF
    Signorini, O
    Gotti, E
    Remuzzi, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3314 - A3314
  • [39] Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients
    Baruch, Y
    Assy, N
    Kramsky, R
    Enat, R
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1852 - 1853
  • [40] Conversion from Sandimmune to neoral in stable pediatric liver transplant recipients
    Zylber-Katz, E
    Doron, D
    Granot, E
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (04) : 1915 - 1917